BRAF and NRAS mutation status and response to checkpoint inhibition in advanced melanoma.

被引：0
|
作者：
van Not, Olivier Jules
van den Eertwegh, Alfonsus Johannes Maria
Haanen, John B. A. G.
Blank, Christian U.
Aarts, Maureen J. B.
van den Berkmortel, Franchette
de Groot, Jan Willem
Hospers, Geke
Kapiteijn, Ellen
Piersma, Djura
Van Rijn, Rozemarijn
Stevense, Marion
Van Der Veldt, Astrid Aplonia Maria
Vreugdenhil, Gerard
Boers-Sonderen, Marye
Bonenkamp, Han J.
Jansen, Anne M. L.
Blokx, Willeke
Wouters, Michel W. J. M.
Suijkerbuijk, Karijn
机构：
[1] Univ Med Ctr Utrecht, Leiden, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[5] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[6] Zuyderland Hosp, Heerlen, Netherlands
[7] Oncol Ctr Isala, Zwolle, Netherlands
[8] Univ Groningen, Med Ctr, Groningen, Netherlands
[9] Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands
[10] MST, Enschede, Netherlands
[11] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[12] Amphia Hosp, Dept Internal Med, Breda, Netherlands
[13] Erasmus MC, Dept Med Oncol & Radiol, Rotterdam, Netherlands
[14] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands
[15] Radboudumc, Nijmegen, Netherlands
[16] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[17] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9558
引用
收藏
页数：3
相关论文
共 50 条
  • [1] BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma
    van Not, Olivier J.
    Blokx, Willeke A. M.
    van den Eertwegh, Alfons J. M.
    de Meza, Melissa M.
    Haanen, John B.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Boers-Sonderen, Marye J.
    Jansen, Anne M. L.
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn P. M.
    [J]. JCO PRECISION ONCOLOGY, 2022, 6
  • [2] BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma
    van Not, Olivier J.
    Blokx, Willeke A. M.
    van den Eertwegh, Alfons J. M.
    de Meza, Melissa M.
    Haanen, John B.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Boer, Marion Stevense-den
    Van der Veldt, Astrid A. M.
    Boers-Sonderen, Marye J.
    Jansen, Anne M. L.
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn P. M.
    [J]. JCO PRECISION ONCOLOGY, 2022, 6
  • [3] A prediction model for response to immune checkpoint inhibition in advanced melanoma.
    van Duin, Isabella A. J.
    Verheijden, Rik Jasper
    van Diest, Paul J.
    van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    van Not, Olivier Jules
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Haanen, John B. A. G.
    Hospers, Geke
    Piersma, Djura
    van Rijn, Rozemarijn
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Stevense-den Boer, Marion
    Boers-Sonderen, Marye J.
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Elias, Sjoerd G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Efficacy of checkpoint inhibition in advanced acral melanoma.
    de Meza, Melissa Melanie
    van Not, Olivier Jules
    Blokx, Willeke
    Bonenkamp, Han J.
    Blank, Christian U.
    van den Eertwegh, Alfonsus Johannes Maria
    Aarts, Maureen J. B.
    Stevense, Marion
    van den Berkmortel, Franchette
    Boers-Sonderen, Marye
    de Groot, Jan Willem
    Haanen, John B. A. G.
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Suijkerbuijk, Karijn
    Wouters, Michel W. J. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Inhibition of Mutated BRAF in Melanoma.
    Kim, Taegyun
    Kim, Jihyun
    Lee, Min-Geol
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2261 - 2261
  • [6] Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma
    Carlino, M. S.
    Haydu, L. E.
    Kakavand, H.
    Menzies, A. M.
    Hamilton, A. L.
    Yu, B.
    Ng, C. C.
    Cooper, W. A.
    Thompson, J. F.
    Kefford, R. F.
    O'Toole, S. A.
    Scolyer, R. A.
    Long, G. V.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 111 (02) : 292 - 299
  • [7] BRAF, NRAS, and KIT mutational analysis of spindle cell melanoma.
    Dorkhom, S. J.
    Kim, J.
    Lazar, A. J. F.
    Davies, M. A.
    Homsi, J.
    Papadopoulos, N. E.
    Hwu, W.
    Bedikian, A. Y.
    Woodman, S. E.
    Patel, S. P.
    Hwu, P.
    Kim, K. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma
    M S Carlino
    L E Haydu
    H Kakavand
    A M Menzies
    A L Hamilton
    B Yu
    C C Ng
    W A Cooper
    J F Thompson
    R F Kefford
    S A O'Toole
    R A Scolyer
    G V Long
    [J]. British Journal of Cancer, 2014, 111 : 292 - 299
  • [9] Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma
    Pozzobon, F. C.
    Puig-Butille, J. A.
    Gonzalez-Alvarez, T.
    Carrera, C.
    Aguilera, P.
    Alos, L.
    Badenas, C.
    Grichnik, J. M.
    Malvehy, J.
    Puig, S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (04) : 754 - 759
  • [10] BRAF -, NRAS- and TERT- Mutation Status in Patients with Multiple Melanoma
    Egberts, F.
    Bohne, A. -S.
    Krueger, S.
    Haag, J.
    Hedderich, J.
    Rompel, R.
    Roecken, C.
    Hauschild, A.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 7 - 7
12345